Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
Public ClinicalTrials.gov record NCT04084769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults
Study identification
- NCT ID
- NCT04084769
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Enrollment
- 570 participants
Conditions and interventions
Interventions
- Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine Biological
- Meningococcal Group B vaccine (Trumenba®) Biological
- Meningococcal group B vaccine (Bexsero®) Biological
Biological
Eligibility (public fields only)
- Age range
- 13 Years to 26 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2, 2019
- Primary completion
- Sep 13, 2020
- Completion
- Sep 13, 2020
- Last update posted
- Sep 14, 2025
2019 – 2020
United States locations
- U.S. sites
- 29
- U.S. states
- 12
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 8400012 | Birmingham | Alabama | 35205 | — |
| Investigational Site Number 8400005 | San Diego | California | 92123-1881 | — |
| Investigational Site Number 8400013 | Bardstown | Kentucky | 40004 | — |
| Investigational Site Number 8400033 | Lexington | Kentucky | 40517 | — |
| Investigational Site Number 8400034 | Bridgeton | Missouri | 63044 | — |
| Investigational Site Number 8400027 | Lincoln | Nebraska | 68504 | — |
| Investigational Site Number 8400002 | Lincoln | Nebraska | 68505 | — |
| Investigational Site Number 8400004 | Lincoln | Nebraska | 68516 | — |
| Investigational Site Number 8400030 | Dayton | Ohio | 45414 | — |
| Investigational Site Number 8400028 | South Euclid | Ohio | 44121 | — |
| Investigational Site Number 8400009 | Norman | Oklahoma | 73069 | — |
| Investigational Site Number 8400038 | Erie | Pennsylvania | 16505 | — |
| Investigational Site Number 8400039 | Charleston | South Carolina | 29414 | — |
| Investigational Site Number 8400018 | Kingsport | Tennessee | 37660 | — |
| Investigational Site Number 8400029 | Tullahoma | Tennessee | 37388 | — |
| Investigational Site Number 8400031 | Kaysville | Utah | 84037 | — |
| Investigational Site Number 8400001 | Layton | Utah | 84041 | — |
| Investigational Site Number 8400014 | Layton | Utah | 84041 | — |
| Investigational Site Number 8400040 | Orem | Utah | 84057 | — |
| Investigational Site Number 8400011 | Provo | Utah | 84064 | — |
| Investigational Site Number 8400023 | Roy | Utah | 84067 | — |
| Investigational Site Number 8400003 | Salt Lake City | Utah | 84107 | — |
| Investigational Site Number 8400007 | Salt Lake City | Utah | 84109 | — |
| Investigational Site Number 8400022 | Salt Lake City | Utah | 84109 | — |
| Investigational Site Number 8400015 | South Jordan | Utah | 84095 | — |
| Investigational Site Number 8400036 | South Jordan | Utah | 84095 | — |
| Investigational Site Number 8400032 | Syracuse | Utah | 84075-9645 | — |
| Investigational Site Number 8400024 | West Jordan | Utah | 84088-8865 | — |
| Investigational Site Number 8400037 | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04084769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2025 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04084769 live on ClinicalTrials.gov.